New challenges in the study of the mammalian tachykinins

Peptides

Volumn 26, Issue 8, 2005, Pages 1356-1368

  Page, Nigel M ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Endokinin; Hemokinin; Isoform; Long; Neurokinin; Peptide; Receptor; Short; Substance P; Tachykinin; Tachykinin NK1 receptor; Virokinin

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; ENZYME INHIBITOR; LY 306740; NALOXONE; NOLPITANTIUM; PHYSALAEMIN[9 DEXTRO PROLINE SPIRO GAMMA LACTAM 10 LEUCINE 11 TRYPTOPHAN]; PREPROTACHYKININ; RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; SAREDUTANT; SUBSTANCE P; TACHYKININ; TACHYKININ RECEPTOR AGONIST;

BINDING SITE; CONFERENCE PAPER; HUMAN; MAMMAL; MOLECULE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RNA SPLICING; TISSUE SPECIFICITY;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; RECEPTORS, TACHYKININ; TACHYKININS;

MAMMALIA;

EID: 22544486550     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2005.03.030     Document Type: Conference Paper

References (113)

1. S.J. Baker, J.L. Morris, and I.L. Gibbins Cloning of a C-terminally truncated NK-1 receptor from guinea-pig nervous system. Brain Res Mol Brain Res 111 2003 136 147
2. P.S. Bandari, J. Qian, G. Yehia, D.D. Joshi, P.B. Maloof, and J. Potian Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P Regul Pept 111 2003 169 178
3. M.J. Bannon, M.S. Poosch, D.M. Haverstick, A. Mandal, I.C. Xue, and K. Shibata Preprotachykinin gene expression in the human basal ganglia: characterization of mRNAs and pre-mRNAs produced by alternate RNA splicing Brain Res Mol Brain Res 12 1992 225 231
4. J.C. Beaujouan, M. Saffroy, Y. Torrens, and J. Glowinski Different subtypes of tachykinin NK(1) receptor binding sites are present in the rat brain J Neurochem 75 2000 1015 1026
5. J.C. Beaujouan, M. Saffroy, Y. Torrens, S. Sagan, and J. Glowinski Pharmacological characterization of tachykinin septide-sensitive binding sites in the rat submaxillary gland Peptides 20 1999 1347 1352
6. J.C. Beaujouan, Y. Torrens, M. Saffroy, M.L. Kemel, and J. Glowinski A 25 year adventure in the field of tachykinins Peptides 25 2004 339 357
7. F. Bellucci, F. Carini, C. Catalani, P. Cucchi, A. Lecci, and S. Meini Pharmacological profile of the novel mammalian tachykinin, hemokinin 1 Br J Pharmacol 135 2002 266 274
8. F.E. Blaney, L.F. Raveglia, M. Artico, S. Cavagnera, C. Dartois, and C. Farina Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists J Med Chem 44 2001 1675 1689
9. S.K. Bohm, L.M. Khitin, S.P. Smeekens, E.F. Grady, D.G. Payan, and N.W. Bunnett Identification of potential tyrosine-containing endocytic motifs in the carboxyl-tail and seventh transmembrane domain of the neurokinin 1 receptor J Biol Chem 272 1997 2363 2372
10. E.R. Brown, K.A. Roth, and J.E. Krause Sexually dimorphic distribution of substance P in specific anterior pituitary cell populations Proc Natl Acad Sci USA 88 1991 1222 1226
11. G. Buell, M.F. Schulz, S.J. Arkinstall, K. Maury, M. Missotten, and N. Adami Molecular characterisation, expression and localisation of human neurokinin-3 receptor FEBS Lett 299 1992 90 95
12. L. Caberlotto, Y.L. Hurd, P. Murdock, J.P. Wahlin, S. Melotto, and M. Corsi Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain Eur J Neurosci 17 2003 1736 1746
13. V. Camarda, A. Rizzi, G. Calo, R. Guerrini, S. Salvadori, and D. Regoli Pharmacological profile of hemokinin 1: a novel member of the tachykinin family Life Sci 71 2002 363 370
14. M.L. Candenas, C.G. Cintado, J.N. Pennefather, M.T. Pereda, J.M. Loizaga, and C.A. Maggi Identification of a tachykinin NK(2) receptor splice variant and its expression in human and rat tissues Life Sci 72 2002 269 277
15. M.S. Carter, J.E. Krause, and Structure expression, and some regulatory mechanisms of the rat preprotachykinin gene encoding substance P, neurokinin A, neuropeptide K, and neuropeptide gamma J Neurosci 10 1990 2203 2214
16. M.A. Cascieri, R.R. Huang, T.M. Fong, A.H. Cheung, S. Sadowski, and E. Ber Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors Mol Pharmacol 41 1992 1096 1099
17. E. Cellier, L. Barbot, S. Iyengar, and R. Couture Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat Br J Pharmacol 127 1999 717 728
18. E. Cellier, L. Barbot, D. Regoli, and R. Couture Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat Br J Pharmacol 122 1997 643 654
19. M.M. Chang, S.E. Leeman, and H.D. Niall Amino-acid sequence of substance P Nat New Biol 232 1971 86 87
20. A. Ciucci, C. Palma, S. Manzini, and T.M. Werge Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide Br J Pharmacol 125 1998 393 401
21. R. Couture, N. Toma, and L. Barbot SR142801 behaves as a tachykinin NK-3 receptor agonist on a spinal nociceptive reflex in the rat Life Sci 66 2000 51 65
22. J.D. Cremins, J. Michel, J.M. Farah, and J.E. Krause Characterization of substance P-like immunoreactivity and tachykinin-encoding mRNAs in rat medullary thyroid carcinoma cell lines J Neurochem 58 1992 817 825
23. O. Dery, K.A. Defea, and N.W. Bunnett Protein kinase C-mediated desensitization of the neurokinin 1 receptor Am J Physiol Cell Physiol 280 2001 1097 1106
24. L.F. Donaldson, C.A. Haskell, and M.R. Hanley Functional characterization by heterologous expression of a novel cloned tachykinin peptide receptor Biochem J 320 1996 1 5
25. R.A. Duffy, J.A. Hedrick, G. Randolph, C.A. Morgan, M.E. Cohen-Williams, and G. Vassileva Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils Neuropharmacology 45 2003 242 250
26. T.M. Fong, S.A. Anderson, H. Yu, R.R. Huang, and C.D. Strader Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor Mol Pharmacol 41 1992 24 30
27. N.P. Gerard, R.L. Eddy Jr., T.B. Shows, and C. Gerard The human neurokinin A (substance K) receptor. Molecular cloning of the gene, chromosome localization, and isolation of the cDNA from tracheal and gastric tissues J Biol Chem 266 1991 1354
28. N.P. Gerard, L.A. Garraway, R.L. Eddy Jr., T.B. Shows, H. Iijima, and J.L. Paquet Human substance P receptor (NK-1): organization of the gene, chromosome localization, and functional expression of cDNA clones Biochemistry 30 1991 10640 10646
29. J. Glowinski The 'septide-sensitive' tachykinin receptor: still an enigma Trends Pharmacol Sci 16 1995 365 367
30. G.J. Graham, J.M. Stevens, N.M. Page, A.D. Grant, S.D. Brain, and P.J. Lowry Tachykinins regulate the function of platelets Blood 104 2004 1058 1065
31. A.D. Grant, R. Akhtar, N.P. Gerard, S.D. Brain, and Neurokinin B induces oedema formation in mouse lung via tachykinin receptor-independent mechanisms J Physiol 543 2002 1007 1014
32. J.W. Growcott, A. Jamieson, A.V. Tarpey, and L.D. Topham Further evidence for multiple tachykinin receptors Eur J Pharmacol 86 1982 59 64
33. M.E. Hall, and J.M. Stewart Modulation of isolation-induced fighting by N- and C-terminal analogs of substance P: evidence for multiple recognition sites Peptides 5 1984 85 89
34. M. Hallberg, and F. Nyberg Neuropeptide conversion to bioactive fragments - an important pathway in neuromodulation Curr Protein Pept Sci 4 2003 31 44
35. A.J. Harmar, V. Hyde, and K. Chapman Identification and cDNA sequence of delta-preprotachykinin, a fourth splicing variant of the rat substance P precursor FEBS Lett 275 1990 22 24
36. H. Hastrup, T.W. Schwartz, Septide, and neurokinin A are high-affinity ligands on the NK-1 receptor: evidence from homologous versus heterologous binding analysis FEBS Lett 399 1996 264 266
37. A.D. Hershey, P.E. Dykema, and J.E. Krause Organization, structure, and expression of the gene encoding the rat substance P receptor J Biol Chem 266 1991 4366 4374
38. B. Holst, H. Hastrup, U. Raffetseder, L. Martini, and T.W. Schwartz Two active molecular phenotypes of the tachykinin NK1 receptor revealed by G-protein fusions and mutagenesis J Biol Chem 276 2001 19793 19799
39. O.J. Igwe, D.C. Kim, V.S. Seybold, and A.A. Larson Specific binding of substance P aminoterminal heptapeptide [SP(1-7)] to mouse brain and spinal cord membranes J Neurosci 10 1990 3653 3663
40. Y. Jiang, G. Gao, G. Fang, E.L. Gustafson, M. Laverty, and Y. Yin a pattern-based oligopeptide homology search method and the identification of a novel tachykinin-like peptide Mamm Genome 14 2003 341 349
41. D.D. Joshi, A. Dang, P. Yadav, J. Qian, P.S. Bandari, and K. Chen Negative feedback on the effects of stem cell factor on hematopoiesis is partly mediated through neutral endopeptidase activity on substance P: a combined functional and proteomic study Blood 98 2001 2697 2706
42. R. Kage, S.E. Leeman, and N.D. Boyd Biochemical characterization of two different forms of the substance P receptor in rat submaxillary gland J Neurochem 60 1993 347 351
43. R. Kage, G.P. McGregor, L. Thim, and J.M. Conlon Neuropeptide-gamma: a peptide isolated from rabbit intestine that is derived from gamma- preprotachykinin J Neurochem 50 1988 1412 1417
44. K. Kangawa, N. Minamino, A. Fukuda, H. Matsuo, and Neuromedin K a novel mammalian tachykinin identified in porcine spinal cord Biochem Biophys Res Commun 114 1983 533 540
45. Y. Kawaguchi, M. Hoshimaru, H. Nawa, and S. Nakanishi Sequence analysis of cloned cDNA for rat substance P precursor: existence of a third substance P precursor Biochem Biophys Res Commun 139 1986 1040 1046
46. M.L. Kemel, S. Perez, J.C. Beaujouan, M. Jabourian, P. Soubrie, and J. Glowinski The new neurokinin 1-sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum J Neurochem 87 2003 487 496
47. V.K. Khare, A.P. Albino, and J.A. Reed The neuropeptide/mast cell secretagogue substance P is expressed in cutaneous melanocytic lesions J Cutan Pathol 25 1998 2 10
48. H.R. Kim, S. Lavielle, and S. Sagan The two NK-1 binding sites are distinguished by one radiolabelled substance P analogue Biochem Biophys Res Commun 306 2003 725 729
49. S. Kimura, K. Okada, Y. Sugita, and Kanazawa I.; Munekata E. Novel peptides neuropeptides, neurokinin alpha and beta, isolated from porcine spinal cord Proc Jpn Acad 59B 1983 101 104
50. H. Kotani, M. Hoshimaru, H. Nawa, and S. Nakanishi Structure and gene organization of bovine neuromedin K precursor Proc Natl Acad Sci USA 83 1986 7074 7078
51. 7]neurokinin B, and is responsive to tachykinin peptide agonists Proc Natl Acad Sci USA 94 1997 310 315
52. M.M. Kurtz, R. Wang, M.K. Clements, M.A. Cascieri, C.P. Austin, and B.R. Cunningham Identification, localization and receptor characterization of novel mammalian substance P-like peptides Gene 296 2002 205 212
53. S. Lang, and G. Sperk Neurochemical characterization of preprotachykinin B(50-79) immunoreactivity in the rat Regul Pept 57 1995 183 192
54. A.H. Lau, S.S. Chow, and Y.S. Ng Immunologically induced histamine release from rat peritoneal mast cells is enhanced by low levels of substance P Eur J Pharmacol 414 2001 295 303
55. R. Laufer, C. Gilon, M. Chorev, and Z. Selinger Desensitization with a selective agonist discriminates between multiple tachykinin receptors J Pharmacol Exp Ther 245 1988 639 643
56. S. Lecat, B. Bucher, Y. Mely, and J.L. Galzi Mutations in the extracellular amino-terminal domain of the NK2 neurokinin receptor abolish cAMP signaling but preserve intracellular calcium responses J Biol Chem 277 2002 42034 42048
57. A. Lecci, and C.A. Maggi Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases Expert Opin Ther Targets 7 2003 343 362
58. Lei, S. Z.; Lipkowski, A. W.; Wilcox, G. L. Opioid and neurokinin activities of substance P fragments and their analogs. Eur J Pharmacol 1991; 193:209-215.
59. H. Li, S.E. Leeman, B.E. Slack, G. Hauser, W.S. Saltsman, and J.E. Krause A substance P (neurokinin-1) receptor mutant carboxyl-terminally truncated to resemble a naturally occurring receptor isoform displays enhanced responsiveness and resistance to desensitization. Proc Natl Acad Sci USA 94 1997 9475 9480
60. M.D. Linnik, and M.A. Moskowitz Identification of immunoreactive substance P in human and other mammalian endothelial cells Peptides 10 1989 957 962
61. J. Longmore, R.G. Hill, and R.J. Hargreaves Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs Canadian J Physio Pharmacol 75 1997 612 621
62. M.R. MacDonald, J. Takeda, C.M. Rice, and J.E. Krause Multiple tachykinins are produced and secreted upon post-translational processing of the three substance P precursor proteins, alpha-, beta-, and gamma-preprotachykinin. Expression of the preprotachykinins in AtT-20 cells infected with vaccinia virus recombinants J Biol Chem 264 1989 15578 15592
63. C.A. Maggi The mammalian tachykinin receptors Gen Pharmacol 26 1995 911 944
64. C.A. Maggi, R. Patacchini, P. Rovero, and A. Giachetti Tachykinin receptors and tachykinin receptor antagonists J Auton Pharmacol 13 1993 23 93
65. P.W. Mantyh, S.D. Rogers, J.R. Ghilardi, J.E. Maggio, C.R. Mantyh, and S.R. Vigna Differential expression of two isoforms of the neurokinin-1 (substance P) receptor in vivo Brain Res 719 1996 8 13
66. S. Meini, R. Patacchini, and C.A. Maggi Tachykinin NK1 receptor subtypes in the rat urinary bladder Br J Pharmacol 111 1994 739 746
67. A. Metwali, A.M. Blum, D.E. Elliott, T. Setiawan, and J.V. Weinstock Cutting edge: hemokinin has substance P-like function and expression in inflammation J Immunol 172 2004 6528 6532
68. 3H]substance P binding and NK1 receptor internalization Neuroreport 10 1999 2209 2213
69. N. Minamino, K. Kangawa, A. Fukuda, H. Matsuo, and Neuromedin L a novel mammalian tachykinin identified in porcine spinal cord Neuropeptides 4 1984 157 166
70. O. Morteau, B. Lu, C. Gerard, and N.P. Gerard Hemokinin 1 is a full agonist at the substance P receptor Nat Immunol 2001 1088
71. S.M. Moussaoui, N. Le Prado, B. Bonici, D.C. Faucher, F. Cuine, and P.M. Laduron Distribution of neurokinin B in rat spinal cord and peripheral tissues: comparison with neurokinin A and substance P and effects of neonatal capsaicin treatment Neuroscience 48 1992 969 978
72. C.J. Mussap, D.P. Geraghty, and E. Burcher Tachykinin receptors: a radioligand binding perspective J Neurochem 60 1993 1987 2009
73. H. Nawa, T. Hirose, H. Takashima, S. Inayama, and S. Nakanishi Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor Nature 306 1983 32 36
74. H. Nawa, H. Kotani, and S. Nakanishi Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing Nature 312 1985 729 734
75. N.M. Page, and endokinins. Hemokinins Cell Mol Life Sci 61 2004 1652 1663
76. N.M. Page, and N.J. Bell The human tachykinin NK1 (short form) and tachykinin NK4 receptor: a reappraisal Eur J Pharmacol 437 2002 27 30
77. N.M. Page, N.J. Bell, S.M. Gardiner, I.T. Manyonda, K.J. Brayley, and P.G. Strange Characterization of the endokinins: human tachykinins with cardiovascular activity Proc Natl Acad Sci USA 100 2003 6245 6250
78. N.M. Page, and P.J. Lowry Is 'pre-eclampsia' simply a response to the side effects of a placental tachykinin? J Endocrinol 167 2000 355 361
79. N.M. Page, R.J. Woods, S.M. Gardiner, K. Lomthaisong, R.T. Gladwell, and D.J. Butlin Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia Nature 405 2000 797 800
80. N.M. Page, R.J. Woods, and P.J. Lowry A regulatory role for neurokinin B in placental physiology and pre-eclampsia Regul Pept 98 2001 97 104
81. R. Patacchini, A. Lecci, P. Holzer, and C.A. Maggi Newly discovered tachykinins raise new questions about their peripheral roles and the tachykinin nomenclature Trends Pharmacol Sci 25 2004 1 3
82. R. Patacchini, and C.A. Maggi Tachykinin receptors and receptor subtypes Arch Int Pharmacodyn Ther 329 1995 161 184
83. R. Patacchini, C.A. Maggi, and P. Holzer Tachykinin autoreceptors in the gut Trends Pharmacol Sci 21 2000 166
84. J.N. Pennefather, A. Lecci, M.L. Candenas, E. Patak, F.M. Pinto, and C.A. Maggi Tachykinins and tachykinin receptors: a growing family Life Sci 74 2004 1445 1463
85. B. Pernow Substance P Pharmacol Rev 35 1983 85 141
86. F. Petitet, J.C. Beaujouan, M. Saffroy, Y. Torrens, and J. Glowinski The nonpeptide NK-2 antagonist SR 48968 is also a NK-3 antagonist in the guinea but not in the rat Biochem Biophys Res Commun 191 1993 180 187
87. F. Petitet, M. Saffroy, Y. Torrens, S. Lavielle, G. Chassaing, and D. Loeuillet Possible existence of a new tachykinin receptor subtype in the guinea pig ileum Peptides 13 1992 383 388
88. P. Picard, and R. Couture Intracerebroventricular responses to neuropeptide gamma in the conscious rat: characterization of its receptor with selective antagonists Br J Pharmacol 117 1996 241 249
89. F.M. Pinto, T.A. Almeida, M. Hernandez, P. Devillier, C. Advenier, and M.L. Candenas mRNA expression of tachykinins and tachykinin receptors in different human tissues Eur J Pharmacol 494 2004 233 239
90. P. Rameshwar, P. Gascon, P.S. Bandari, D.D. Joshi, A. Fernandes, and A. Dang Structural similarity between the bone marrow extracellular matrix protein and neurokinin 1 could be the limiting factor in the hematopoietic effects of substance P Can J Physiol Pharmacol 80 2002 475 481
91. P. Rameshwar, H.S. Oh, C. Yook, P. Gascon, and V.T. Chang Substance P - fibronectin-cytokine interactions in myeloproliferative disorders with bone marrow fibrosis Acta Haematol 109 2003 1 10
92. D. Regoli, A. Boudon, and J.L. Fauchere Receptors and antagonists for substance P and related peptides Pharmacol Rev 46 1994 551 599
93. S. Sagan, J.C. Beaujouan, Y. Torrens, M. Saffroy, G. Chassaing, and J. Glowinski High affinity binding of [3H]propionyl-[Met(O2)11]substance P(7-11), a tritiated septide-like peptide, in Chinese hamster ovary cells expressing human neurokinin-1 receptors and in rat submandibular glands Mol Pharmacol 52 1997 120 127
94. C. Sakurada, C. Watanabe, S. Sakurada, K. Tan-No, and T. Sakurada Major metabolites of substance P degraded by spinal synaptic membranes antagonize the behavioral response to substance P in rats J Pharm Sci 88 1999 1127 1132
95. T. Sakurada, M. Yuhki, M. Inoue, C. Sakurada, K. Tan-No, and M. Ohba Opioid activity of sendide, a tachykinin NK1 receptor antagonist Eur J Pharmacol 369 1999 261 266
96. C. Severini, G. Improta, G. Falconieri-Erspamer, S. Salvadori, and V. Erspamer The tachykinin peptide family Pharmacol Rev 54 2002 285 322
97. J.M. Stewart, M.E. Hall, J. Harkins, R.C. Frederickson, L. Terenius, and T. Hokfelt A fragment of substance P with specific central activity: SP(1-7) Peptides 3 1982 851 857
98. Y. Takeda, K.B. Chou, J. Takeda, B.S. Sachais, and J.E. Krause Molecular cloning, structural characterization and functional expression of the human substance P receptor Biochem Biophys Res Commun 179 1991 1232 1240
99. Y. Takeda, J. Takeda, B.M. Smart, and J.E. Krause Regional distribution of neuropeptide gamma and other tachykinin peptides derived from the substance P gene in the rat Regul Pept 28 3 1990 323 333
100. K. Tateishi, S. Kishimoto, H. Kobayashi, K. Kobuke, and Y. Matsuoka Distribution and localization of neurokinin A-like immunoreactivity and neurokinin B-like immunoreactivity in rat peripheral tissue Regul Pept 30 1990 193 200
101. K. Tatemoto, J.M. Lundberg, H. Jornvall, and V. Mutt Neuropeptide K: isolation, structure and biological activities of a novel brain tachykinin Biochem Biophys Res Commun 128 1985 947 953
102. Y. Torrens, J.C. Beaujouan, M. Saffroy, and J. Glowinski Further evidence for the presence of "septide-sensitive" tachykinin binding sites in tissues possessing solely NK(1) tachykinin receptors Biochem Biophys Res Commun 270 2000 668 672
103. S.R. Vigna Phosphorylation and desensitization of neurokinin-1 receptor expressed in epithelial cells J Neurochem 73 1999 1925 1932
104. S.R. Vigna The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor Neuropeptides 35 2001 24 31
105. S.P. Watson, B.E. Sandberg, M.R. Hanley, and L.L. Iversen Tissue selectivity of substance P alkyl esters: suggesting multiple receptors Eur J Pharmacol 87 1983 77 84
106. J.V. Weinstock The role of substance P, hemokinin and their receptor in governing mucosal inflammation and granulomatous responses Front Biosci 9 2004 1936 1943
107. J.V. Weinstock, A. Blum, J. Walder, and R. Walder Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P J Immunol 141 1988 961 966
108. A. Wijkhuisen, M.A. Sagot, Y. Frobert, C. Creminon, J. Grassi, and D. Boquet Identification in the NK1 tachykinin receptor of a domain involved in recognition of neurokinin A and septide but not of substance P FEBS Lett 447 1999 155 159
109. G.X. Xie, A. Miyajima, and A. Goldstein Expression cloning of cDNA encoding a seven-helix receptor from human placenta with affinity for opioid ligands Proc Natl Acad Sci USA 89 1992 4124 4128
110. Y. Zhang, L. Lu, C. Furlonger, G.E. Wu, and C.J. Paige Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis Nat Immunol 1 2000 392 397
111. Y. Zhang, and C.J. Paige T-cell developmental blockage by tachykinin antagonists and the role of hemokinin 1 in T lymphopoiesis Blood 102 2003 2165 2172
112. Q. Zhou, and F. Nyberg Injection of substance P (SP) N-terminal fragment SP(1-7) into the ventral tegmental area modulates the levels of nucleus accumbens dopamine and dihydroxyphenylacetic acid in male rats during morphine withdrawal Neurosci Lett 320 2002 117 120
113. G. Zimmer, M. Rohn, G.P. McGregor, M. Schemann, K.K. Conzelmann, and G. Herrler a bioactive peptide of the tachykinin family, is released from the fusion protein of bovine respiratory syncytial virus J Biol Chem 278 2003 46854 46861